Detalhe da pesquisa
1.
Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases.
Clin Gastroenterol Hepatol
; 22(1): 135-143.e8, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37442315
2.
Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431223
3.
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial.
J Autoimmun
; 144: 103172, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330545
4.
Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases.
Gut
; 72(7): 1296-1307, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270778
5.
Risk of Recurrent Acute Arterial Events Associated With Thiopurines and Anti-Tumor Necrosis Factor in Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 21(1): 164-172.e11, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35842123
6.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 21(3): 771-788.e10, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152897
7.
Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn's disease.
Gut
; 71(9): 1781-1789, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35387877
8.
Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 20(2): 314-324.e16, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387667
9.
Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study.
Clin Gastroenterol Hepatol
; 20(4): 787-797.e2, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33359726
10.
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy.
Pharmacoepidemiol Drug Saf
; 31(2): 167-175, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498314
11.
Genetic effects on the commensal microbiota in inflammatory bowel disease patients.
PLoS Genet
; 15(3): e1008018, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30849075
12.
Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.
PLoS Genet
; 15(5): e1008190, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31145742
13.
Perspectives From Patients and Gastroenterologists on De-escalating Therapy for Crohn's Disease.
Clin Gastroenterol Hepatol
; 19(2): 403-405, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31887442
14.
Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.
Gastroenterology
; 159(6): 2193-2202.e5, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32860788
15.
A Scoring System to Determine Patients' Risk of Colectomy Within 1 Year After Hospital Admission for Acute Severe Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 19(8): 1602-1610.e1, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31927106
16.
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine.
Clin Gastroenterol Hepatol
; 19(6): 1180-1188.e4, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777552
17.
Postoperative diagnostic revision for Crohn disease after subtotal colectomy for inflammatory bowel disease.
Int J Colorectal Dis
; 36(4): 709-715, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33084950
18.
Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.
PLoS Genet
; 14(5): e1007329, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29795570
19.
Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study.
Gut
; 69(5): 852-858, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446428
20.
Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 18(6): 1324-1335.e2, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32059920